Low power methodology manual for system-on-chip design /

Por Keating, Michael
Publicado em 2007

A Unique Finger Injury in a Professional Hockey Player: A Case Report

Por Keating, Michael J.
Publicado em 1999

Points from Letters: Synthetic Drugs and Carcinoma

Por Keating, Michael J.
Publicado em 1964

Migratory Pruritus

Por Keating, Michael J.
Publicado em 1960

Reuse methodology manual for system-on-a-chip designs /

Por Keating, Michael, Bricaud, Pierre.
Publicado em 1999

Naciones contra el Estado : el nacionalismo de Cataluña, Quebec y Escocia /

Por Keating, Michael, Beltrán, Sordi.
Publicado em [199

The significance of spliceosome mutations in chronic lymphocytic leukemia

Por Rozovski, Uri, Keating, Michael, Estrov, Zeev
Publicado em 2013

Targeting Inflammatory Pathways in Chronic Lymphocytic Leukemia

Por Rozovski, Uri, Keating, Michael J., Estrov, Zeev
Publicado em 2013

Blood collection methods affect cellular protein integrity: implications for clinical trial biomarkers and ZAP-70 in CLL

Por Chen, Lisa S., Keating, Michael J., Gandhi, Varsha
Publicado em 2014

Pharmacokinetic and pharmacodynamic evaluation of ibrutinib for the treatment of chronic lymphocytic leukemia: rationale for lower doses

Por Bose, Prithviraj, Gandhi, Varsha V., Keating, Michael J.
Publicado no Expert Opin Drug Metab Toxicol (2016)

Pharmacotherapy of relapsed/refractory chronic lymphocytic leukemia

Por Zahr, Abdallah Abou, Bose, Prithviraj, Keating, Michael J.
Publicado no Expert Opin Pharmacother (2017)

Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death

Por Chen, Rong, Keating, Michael J., Gandhi, Varsha, Plunkett, William
Publicado em 2005

Public Policy to Reduce Inequalities across Europe

Por Cairney, Paul, Keating, Michael, Kippin, Sean, St Denny, Emily
Publicado em 2022

Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removal

Por Moufarij, Mazin A., Sampath, Deepa, Keating, Michael J., Plunkett, William
Publicado em 2006

Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells

Por Balakrishnan, Kumudha, Wierda, William G., Keating, Michael J., Gandhi, Varsha
Publicado em 2008

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL)

Por Al-Kali, Aref, Wierda, William, Keating, Michael, O’Brien, Susan
Publicado em 2010

Personalized medicine in CLL: Current status and future perspectives

Por Rozovski, Uri, Hazan-Halevy, Inbal, Keating, Michael J., Estrov, Zeev
Publicado em 2013

Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy

Por THOMAS, DEBORAH A., RAVANDI, FARHAD, KEATING, MICHAEL, KANTARJIAN, HAGOP M.
Publicado em 2009

Pregnancy in a patient with hypereosinophilic syndrome

Por Ault, Patricia, Cortes, Jorge, Lynn, Alice, Keating, Michael, Verstovsek, Srdan
Publicado no Leuk Res (2008)

Preclinical combination of TP-0903, an AXL inhibitor and B-PAC-1, a procaspase-activating compound with ibrutinib in chronic lymphocytic leukemia

Por Patel, Viralkumar, Keating, Michael J., Wierda, William G., Gandhi, Varsha
Publicado no Leuk Lymphoma (2015)